<DOC>
	<DOC>NCT01694225</DOC>
	<brief_summary>This study aims to establish the feasibility of using a monthly bubble package to improve compliance rates among women prescribed adjuvant endocrine therapy.</brief_summary>
	<brief_title>Adherence Rate of Monthly Bubble Package Among Patients Prescribed Adjuvant Endocrine Therapy in Breast Cancer Survivors</brief_title>
	<detailed_description>This study uses Bubble packaging to provide a cost effective way to improve compliance and help direct further interventions to ensure adherence in women on anti-estrogen therapy for breast cancer.</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>18 years of age or older Estrogen receptor positive (&gt; 1% estrogen expression) by immunohistochemistry Invasive breast cancer (stage I, II, III) or DCIS considered for adjuvant endocrine therapy Patients with metastatic disease (stage IV) Patients less than 18 years of age Prisoners Patients are unable to fill prescriptions at the BCC pharmacy due to insurance limitations or personal preference</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Breast cancer</keyword>
	<keyword>Anti-estrogen therapy</keyword>
</DOC>